AVALYN PHARMACEUTICALS INC (AVLN): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in AVLN. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
2
13F filers
Aggregate Value
$4.0M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity2 increased0 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| MOORE CAPITAL MANAGEMENT, LP CIK 0001448574 | Hedge Fund | 110K | $3.6M | 91.7% | 0.1% | Added | — | Q2 2026 |
| SOROS FUND MANAGEMENT LLC CIK 0001029160 | Family Office | 10K | $329K | 8.3% | 0.0% | Added | — | Q2 2026 |
Loading recent insider activity…